C6D6): d 149.5, 112.4, 110.0 (C5H4), 62.6 (NCH2), 48.7 (N(CH3)),
42.0 (C(CH3)2), 31.9 (C(CH3)2), 31.2 (CH2CH2CH2), the cage
carbons were not observed. 11B NMR (128 MHz, C6D6): d −2.6
(2B), −5.6 (2B), −8.9 (4B), −11.7 (2B). IR (KBr, cm−1): m 2598
(vs), 2565 (vs), 2540 (vs) (B–H). Anal. calcd for C15H32B10N2Ti:
C, 45.45; H, 8.14; N, 7.07. Found: C, 44.92; H, 7.95; N, 7.26%.
33.2 (C(CH3)2), 21.3, 20.5 (C6H3(CH3)2), the cage carbons were
not observed. 11B NMR (128 MHz, pyridine-d5): d −3.9 (2B),
−5.9 (2B), −9.2 (3B), −10.3 (2B), −13.4 (1B). IR (KBr, cm−1):
m 2598 (vs), 2538 (vs) (B–H). Anal. calcd for C32H48B10N4Ti: C,
59.61; H, 7.50; N, 8.69. Found: C, 59.88; H, 7.65; N, 8.40%.
Preparation
of
[g5:r-Me2C(C5H4)(C2B10H10)]Zr[g2:g2-
Preparation of [g5:r-Me2C(C5H4)(C2B10H10)]Zr[g2-N(Me)-
CH2CH2CH2N(Me)] (2b). To a toluene (15 mL) solution of
[g :r-Me2C(C5H4)(C2B10H10)]Zr(NMe2)2 (214 mg, 0.5 mmol) was
=
=
XyN CN(Me)(CH2)2N(Me)C NXy]
(3b). This
complex
was prepared as colorless crystals from 1b (235 mg, 0.5 mmol)
and XyNC (131 mg, 1.0 mmol) in toluene using an identical
procedure to that reported for 3a: yield 247 mg (68%). Crystals
suitable for X-ray analyses were grown from a benzene–THF
solution at room temperature. 1H NMR (300 MHz, pyridine-d5):
d 7.08 (m, 6H) (C6H3), 6.05 (m, 4H) (C5H4), 3.87 (dd, J = 8.4
and 7.2 Hz, 2H), 3.36 (m, 2H) (NCH2), 2.51 (s, 6H) (NCH3),
2.29 (s, 6H), 1.91 (s, 6H) (C6H3(CH3)2), 1.71 (s, 6H) (C(CH3)2).
13C NMR (75 MHz, pyridine-d5): d 207.4 (C=N), 146.8, 146.7,
130.9, 130.7, 128.9, 127.5, 127.3, 124.0, 121.4 (aryl C), 105.5,
102.4 (C5H4), 54.7 (NCH2), 42.0 (C(CH3)2), 35.1 (NCH3), 32.6
(C(CH3)2), 19.6, 18.8 (C6H3(CH3)2), the cage carbons were not
observed. 11B NMR (128 MHz, pyridine-d5): d −3.3 (2B), −5.3
(2B), −9.1 (5B), −13.3 (1B). IR (KBr, cm−1): m 2554 (vs) (B–H).
Anal. calcd for C32H48B10N4Zr: C, 55.86; H, 7.03; N, 8.14. Found:
C, 55.40; H, 7.39; N, 7.86%.
5
added dropwise a toluene (8 mL) solution of MeNH(CH2)3NHMe
(56 mg, 0.55 mmol) at 0 ◦C with stirring. The mixture was warmed
to room temperature and stirred overnight. After filtration, the
resulting yellow solution was concentrated under vacuum to
about 8 mL. Complex 2b was isolated as yellow crystals after this
solution had stood at room temperature for 2 d (179 mg, 82%). 1H
NMR (300 MHz, C6D6): d 5.66 (d, J = 2.7 Hz, 2H), 5.61 (d, J =
2.7 Hz, 2H) (C5H4), 2.90 (m, 4H) (NCH2), 2.66 (s, 6H) (N(CH3)),
1.97 (m, 2H), (CH2CH2CH2), 1.40 (s, 6H) (C(CH3)2). 13C NMR
(75 MHz, C6D6): d 146.4, 113.0, 109.3 (C5H4), 57.3 (NCH2), 46.0
(N(CH3)), 42.5 (C(CH3)2), 32.6 (C(CH3)2), 27.4 (CH2CH2CH2),
the cage carbons were not observed. 11B NMR (128 MHz, C6D6):
d −2.3 (2B), −5.1 (2B), −8.6 (2B), −9.2 (2B), −11.9 (2B). IR
(KBr, cm−1): m 2562 (vs) (B–H). Anal. calcd for C15H32B10N2Zr: C,
40.97; H, 7.33; N, 6.37. Found: C, 40.99; H, 7.74; N, 6.13%.
Preparation of [g5:r-Me2C(C5H4)(C2B10H10)]Hf[g2-N(Me)-
CH2CH2CH2N(Me)] (2c). This complex was prepared as yellow
crystals from [g :r-Me2C(C5H4)(C2B10H10)]Hf(NMe2)2 (258 mg,
Preparation of {[g5:r-Me2C(C5H4)(C2B10H10)]Zr[l-g2:g2-OCN-
(Ph)N(Me)CH2CH2(Me)N(Ph)NCO]}2 (4b). To a DME (30 mL)
solution of 1b (235 mg, 0.5 mmol) was added dropwise a DME
(10 mL) solution of PhNCO (112 mg, 1.0 mmol) at −30 ◦C with
stirring. The mixture was warmed to room temperature and stirred
for 10 min. After filtration, the resulting pale yellow solution was
concentrated under vacuum to about 30 mL. Complex 4b was
isolated as colorless crystals after this solution had stood at room
temperature for 2 d (228 mg, 69%). 1H NMR (300 MHz, pyridine-
d5): d 9.13 (brs, 2H), 7.98 (d, J = 7.8 Hz, 6H), 7.64 (dd, J = 7.8 and
6.9 Hz, 8H), 7.03 (dd, J = 7.8 and 6.9 Hz, 4H) (C6H5), 6.62–6.17
(m, 8H) (C5H4), 3.57 (brs, 8H) (NCH2), 3.06 (s, 12H) (N(CH3)),
1.44 (s, 12H) (C(CH3)2). 13C NMR (75 MHz, pyridine-d5): d 156.1
5
0.5 mmol) and MeNH(CH2)3NHMe (56 mg, 0.55 mmol) in
toluene using an identical procedure to that reported for 2b:
1
yield 214 mg (82%). H NMR (300 MHz, C6D6): d 5.59 (d, J =
2.1 Hz, 2H), 5.57 (d, J = 2.1 Hz, 2H) (C5H4), 3.01 (m, 4H)
(NCH2), 2.75 (s, 6H) (N(CH3)), 1.78 (m, 2H) (CH2CH2CH2),
1.38 (s, 6H) (C(CH3)2). 13C NMR (75 MHz, C6D6): d 145.8, 112.0,
108.7 (C5H4), 57.8 (NCH2), 45.1 (N(CH3)), 42.0 (C(CH3)2),
32.5 (C(CH3)2), 28.2 (CH2CH2CH2), the cage carbons were not
observed. 11B NMR (128 MHz, C6D6): d −1.4 (1B), −2.1 (1B),
−4.9 (2B), −8.9 (4B), −12.0 (2B). IR (KBr, cm−1): m 2566 (vs)
(B–H). Anal. calcd for C15H32B10N2Hf: C, 34.18; H, 6.12; N, 5.32.
Found: C, 34.11; H, 6.57; N, 4.78%.
=
(N–C O), 140.9, 132.0, 129.1, 128.7, 128.3, 128.0, 121.9, 120.1
(aryl C + C5H4), 57.9 (NCH2), 46.9 (NCH3), 40.7 (C(CH3)2),
34.9, 29.9 (C(CH3)2), the cage carbons were not observed. 11B
NMR (128 MHz, pyridine-d5): d −3.7 (6B), −9.0 (4B), −11.2
(4B), −13.3 (6B). IR (KBr, cm−1): m 2549 (vs) (B–H). Anal. calcd
for C56H80B20N8O2Zr2: C, 50.65; H, 6.07; N, 8.44. Found: C, 50.42;
H, 6.40; N, 8.24%.
Preparation
of
[g5:r-Me2C(C5H4)(C2B10H10)]Ti[g2:g2-
=
=
XyN CN(Me)(CH2)2N(Me)C NXy] (3a). To
a
toluene
(15 mL) solution of 1a (190 mg, 0.5 mmol) was added dropwise
a toluene (8 mL) solution of XyNC (2,6-Me2C6H3NC) (131 mg,
◦
1.0 mmol) at −30 C with stirring. The mixture was warmed to
room temperature and stirred overnight. After filtration, the white
solid was collected and redissolved in THF (20 mL). The resulting
pale-yellow solution was concentrated to about 8 mL. Complex
3a was isolated as yellow crystals after this solution had stood
at room temperature for 2 d (225 mg, 66%). Crystals suitable
for X-ray analyses were grown from a benzene–THF solution at
Preparation of {[g5:r-Me2C(C5H4)(C2B10H10)]Zr[g2-N(Me)-
= =
(CH2)2NH(Me)][l-TMSN C N]}2 (5b). To a toluene (15 mL)
solution of 1b (235 mg, 0.5 mmol) was added dropwise a toluene
= =
(8 mL) solution of TMSN C NTMS (170 mg, 1.0 mmol) at
−30 ◦C with stirring, and the mixture was warmed to room
temperature and stirred overnight. After filtration, the resulting
clear orange solution was concentrated under vacuum to about
10 mL. Complex 5b was isolated as yellow crystals after this
solution had stood at room temperature for 5 d (142 mg, 53%).
1H NMR (300 MHz, pyridine-d5): d 6.65 (d, J = 2.7 Hz, 1H),
6.46 (d, J = 2.7 Hz, 1H), 5.88 (d, J = 2.7 Hz, 1H), 5.18 (d, J =
2.7 Hz, 1H) (C5H4), 3.61 (m, 2H), 3.18 (m, 2H) (CH3NCH2),
1
room temperature. H NMR (300 MHz, pyridine-d5): d 7.09 (m,
6H) (C6H3), 5.85 (d, J = 2.4 Hz, 2H), 5.83 (d, J = 2.4 Hz, 2H)
(C5H4), 3.81 (dd, J = 8.4 and 7.2 Hz, 2H), 3.38 (m, 2H) (NCH2),
2.53 (s, 6H) (N(CH3)), 2.27 (s, 6H), 1.94 (s, 6H) (C6H3(CH3)2),
1.72 (s, 6H) (C(CH3)2). 13C NMR (75 MHz, pyridine-d5): d 203.9
=
(C N), 148.2, 147.5, 133.0, 132.6, 129.0, 128.4, 125.4 (aryl C),
105.4, 103.0 (C5H4), 53.7 (NCH2), 42.3 (C(CH3)2), 36.8 (NCH3),
This journal is
The Royal Society of Chemistry 2008
Dalton Trans., 2008, 1454–1464 | 1461
©